
Focuses on leading US large-cap stocks, diversified across technology, healthcare, and consumer sectors, suitable for beginners aiming for steady growth without sacrificing potential.
A golden ratio of S&P 500 ETF + Nasdaq ETF, balanced offense and defense, suitable for long-term holding. Tech growth + large-cap stability, sleep well and earn steadily!
Carefully selected popular Hong Kong IPO sectors, gathering the three major blocks of technological innovation, pharmaceuticals, and brokerages to seize the 2026 wave of Hong Kong's new economy. The portfolio includes IPO capital operators and innovative drug leaders like Goldman Sachs, Morgan Stanley, China International Capital Corporation, and Ascentage Pharma.
A handpicked squad of US dividend legends and ETFs for stable income and peace of mind. Includes SCHD, Conagra, Altria, Permian Resources, and Unity Software for a dash of growth.
Carefully selected leading U.S. new energy stocks, covering solar energy, hydrogen energy, batteries, and clean energy. Suitable for long-term investors optimistic about the global energy transition, with diversified allocation and strong risk resistance.
Hop on the AI hype train with the market’s top conductors: NVIDIA, Microsoft, Amazon, Broadcom, and a dash of NVDW for extra spice. This portfolio blends chip power, cloud muscle, and ecommerce scale for a wild but balanced ride.
Hop on the AI hype train with the market’s top conductors: NVIDIA, Microsoft, Amazon, and Broadcom. This portfolio blends chip power, cloud muscle, and ecommerce scale for a wild but balanced ride. Diversification keeps you on track even if one wagon wobbles.
Combining your laid-back holdings with the market's main themes, carefully selected Nvidia, Tesla, Meta, Gold ETF, and Bitcoin ETF—enjoy the benefits of tech growth while maintaining a solid defensive baseline. Perfect for those who want steady progress with the occasional burst of excitement!
50% in top AI stocks for growth, 50% in gold for stability. This portfolio is ready for both robot revolutions and economic meltdowns. Diversification never looked so shiny and smart!
Global pharmaceutical giants + innovative drug pioneers, including Pfizer, Johnson & Johnson, Merck, Novo Nordisk, Eli Lilly, Moderna, diversifying risk while balancing growth and stability. Suitable for long-term holders optimistic about pharmaceutical innovation.

Generate an AI-powered portfolio in one sentence. Execute with one tap.
Try NowLearn More

Try Bobby free for a limited time — generate AI portfolios in one sentence, execute with one tap.
Download App